A recently published review of the Covid vaccine Sinopharm showed that a fourth jab may not produce an additional increase in antibodies against the Omicron variant of the coronavirus behind the current pandemic. Discovered in South Africa only last November, the variant, which spreads more easily than the Delta variant that was dominant in many … Continue reading China study shows 4th Sinopharm jab offers no increased protection against Omicron